Sign up USA
Proactive Investors - Run By Investors For Investors
Why invest in PBIO?
Pressure BioSciences Inc: THE INVESTMENT CASE

Pressure BioSciences' chief upbeat on company's potential despite recent stock lows

Last month the group revealed its Barocycler 2320EXTREME device had been selected as a finalist in the prestigious R&D 100 Awards for 2017.
Pressure BioSciences' chief upbeat on company's potential despite recent stock lows
INVESTMENT OVERVIEW: PBIO The Big Picture
Pressure BioSciences is at an a'll time high' in terms of potential, says its boss

Pressure BioSciences Inc (OTCMKTS:PBIO) chief Richard T. Schumacher is upbeat on the instrument developer's potential and says it has transformed from where it was nine years ago.

The chief executive recently conducted a podcast on the Uptick Network Stock Day, where he spoke about the firm's growing sales and its sales teams.

From having just one salesperson previously, he told presenter Everett Jolly: "We now have six sales people, we have a brand new award-winning instrument that is opening up doors and areas of biopharma companies, that we could never have got into before."

Last month the group revealed its  next-generation PCT (pressure cycling technology) instrument - the Barocycler 2320EXTREME -  had been selected as a finalist in the prestigious R&D 100 Awards for 2017.

"This company is at an all time high in its potential and its ability to succeed and bring back a great return on investment for investors, and yet we've been hitting our all-time lows in the  past month as a stock price," explained Schumacher.

"Our sales are increasing and our stock price is really not responding."

"We've already broken US$1mln in the first half of the year. In the third quarter, I've already given guidance that investors should expect a record number for our third quarter. Things aren't going down, things are actually moving up.." he added.

Earlier this month, Pressure BioSciences said it was very excited about the potential for its ultra shear technology (UST), for which it has been issued its first two patents in China.

The technology could be used in a range of industrial applications, including extending the shelf life of some food products, the firm said.

The group is a pressure expert and UST is based on using intense shear forces generated from ultra-high pressure valve discharge - greater than 20,000 psi (pound per square inch)

 "The company believes that UST has the potential to play a significant role in a number of commercially important areas, including the formulation of high quality stable nanoemulsions and the preparation of extended shelf-life "clean label" food," it told investors.

Shares in New York added 3.24% on the day to US$4.14 each.

View full PBIO profile View Profile

Pressure BioSciences Inc Timeline

Related Articles

1507647205_biotech_517925923.jpg
October 10 2017
Last month the group revealed its Barocycler 2320EXTREME device had been selected as a finalist in the prestigious R&D 100 Awards for 2017.
ventripoint_device.png
June 21 2017
The device can give accurate and rapid volumetric information about all four chambers of the heart
man at a micrscope
September 29 2017
The company is a specialist in the storage of stems cells from the umbilical cord, which could provide a potentially life-saving treatment for 82 blood-borne diseases

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You understand that the Company receives either monetary or securities compensation for our services. We stand to benefit from any volume this write-up may generate.

You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Copyright © Proactiveinvestors.com, 2017. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use